Showing results (401-410 of 552) with videos related to

Sort By:
Pageof 56
Journal of the American Academy of Dermatology|January 27, 2022
American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adultsDawn M R Davis, Aaron M Drucker, Ali Alikhan, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 18, 2020
Measurement Properties of 4 Patient-Reported Outcome Measures to Assess Sleep Disturbance in Adults With Atopic DermatitisDonald K Lei, Muhammad Yousaf, Sherief R Janmohamed, et al.
American Journal of Clinical Dermatology|May 2, 2024
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 StudiesLawrence F Eichenfield, Eric L Simpson, Kim Papp, et al.
The British Journal of Dermatology|October 22, 2024
Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)Jonathan I Silverberg, Christopher G Bunick, H Chih-Ho Hong, et al.
Dermatology and Therapy|June 18, 2026
Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)Emma Guttman-Yassky, Alan D Irvine, Melinda Gooderham, et al.
Plos One|August 4, 2022
Predictors of chronic COVID-19 symptoms in a community-based cohort of adultsJonathan I Silverberg, Israel Zyskind, Hiam Naiditch, et al.
JAMA Network Open|March 10, 2021
SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United StatesIsrael Zyskind, Avi Z Rosenberg, Jason Zimmerman, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|April 2, 2021
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With AbrocitinibEric L Simpson, Andreas Wollenberg, Robert Bissonnette, et al.
American Journal of Clinical Dermatology|August 18, 2021
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial ProgramEric L Simpson, Jonathan I Silverberg, Audrey Nosbaum, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 19, 2016
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus OpinionJennifer K Chen, Sharon E Jacob, Susan T Nedorost, et al.
Pageof 56